Update on Pakistan Polio Eradication Initiative
DOI:
https://doi.org/10.53685/jshmdc.v3i1.100Keywords:
Pakistan, Poliomyelitis, human poliovirus 1, human poliovirus 2, human poliovirus 3, oral poliovirus vaccineAbstract
The global polio eradication initiative (GPEI) was established in 1988 as a result of the declaration of commitment by the World Health Assembly. In Pakistan, National Emergency Action Plan [NEAP] coined the strategies under government directives to play a pivotal role in line with international requirements to make poliomyelitis extinct. At the program’s initiation, there were around 350,000 cases of polio reported annually. The incidence has fallen by 99% due to the immunization of more than 2.5 billion children worldwide. Poliovirus has three serotypes; two have already been eradicated (the last case of poliovirus type 2 was reported in 1999 and of poliovirus type 3 in 2012). Poliovirus transmission has ceased with the exception of Pakistan and Afghanistan. In April 2022, two cases of acute flaccid paralysis due to poliovirus type 1 have been reported in KPK province. In this communication, insight is provided regarding the issues that have contributed to this wild poliovirus resurgence after a 15-month gap and the way forward.
References
https://www.endpolio.com.pk/images/english-polio-endgame-strategy.pdf (accessed 30 April 2022)
https://en.wikipedia.org/wiki/GAVI
https://polioeradication.org/wp-content/uploads/2016/11/NEAP2016-2017_Pakistan.pdf (accessed 1 May 2022)
https://www.endpolio.com.pk/global-polio-pakistan/history-of-polio (accessed 30 April 2022)
https://www.endpolio.com.pk/polioin-pakistan/polio-cases-in-provincesay (accessed 4 May 2022)
Polio Endgame Strategy 2019-2023: Eradication, integration, certification & Containment. Geneva: World Health Organization;2019(WHO/Polio/19.04). License CC BY-NC-SA 3.0 IGO
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Maryam Riaz Tarar
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material
- The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
-
Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
-
Non Commercial — You may not use the material for commercial purposes.
-
No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
This work is licensed under a 
